The present study aimed to assess the effect of the polymorphisms in TLR2, TLR4, TLR9 and NF-κB1 genes, involved in regulation of the NF-κB pathway, on susceptibility to RA, progression of the disease and response to therapy with TNF-α blocking agents. This evidence concerns the gene TLR4 and rheumatoid arthritis.